NewsRx

Search our medical news database

Endologix

Endologix reports continued significant growth during second quarter in U.S. product sales

Published in Cardiovascular Business Week, August 22nd, 2006

Endologix, Inc. (ELGX), developer and manufacturer of the Powerlink System endoluminal stent graft (ELG) for the minimally invasive treatment of abdominal aortic aneurysms (AAA), announced financial results for the three months and six months ended June 30, 2006.

"Our domestic product sales increased by more than three-fold year-over-year and by 31% on a sequential quarter basis," said Endologix president and chief executive officer Paul McCormick. "We believe our sales growth reflects positively on the steps we are taking to accelerate our domestic launch, including the hiring of sales representatives with prior AAA experience, and indicates an increasing market...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Cardiovascular Business Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook